Deep brain stimulation for obsessive-compulsive disorder is associated with cortisol changes

Psychoneuroendocrinology

Volumn 38, Issue 8, 2013, Pages 1455-1459

  de Koning, Pelle P ^a   Figee, Martijn ^a   Endert, Erik ^a   Storosum, Jitschak G ^a   Fliers, Eric ^a   Denys, Damiaan ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Adrenaline; Cortisol; Deep brain stimulation (DBS); Hypothalamic pituitary adrenal (HPA) axis; Noradrenaline; Obsessive compulsive disorder (OCD)

Indexed keywords

ADRENALIN; HYDROCORTISONE; NORADRENALIN;

ADRENALIN URINE LEVEL; ADULT; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HAMILTON SCALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERMETHOD COMPARISON; MALE; NORADRENALIN URINE LEVEL; NUCLEUS ACCUMBENS; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT FAILURE; URINARY EXCRETION; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; ANXIETY; DEEP BRAIN STIMULATION; DEPRESSION; EPINEPHRINE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NOREPINEPHRINE; NUCLEUS ACCUMBENS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES;

EID: 84878660981     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.12.006     Document Type: Article

References (16)

1. Burtis C.A., Ashwood E.R. Tietz Textbook of Clinical Chemistry 1994, Saunders, Philadelphia. 2nd ed.
2. First M.B., Spitzer R.L., Gibbon M.G., Williams J.N. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I): Clinical Version 1997, American Psychiatric Press, Washington, DC.
3. Fluitman S.B., Denys D.A., Heijnen C.J., Westenberg H.G. Disgust affects TNF-alpha IL-6 and noradrenaline levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology 2010, 35(July (6)):906-911.
4. De Bos Kuil M.J., Endert E., Fliers E., Prummel M.F., Romijn J.A., Wiersinga W.M. Establishment of reference values for endocrine tests. I: Cushing syndrome. Neth. J. Med. 1998, 53:153-163.
5. De Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
6. De Koning P.P., Figee M., van den Munckhof P., Schuurman P.R., Denys D. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr. Psychiatry Rep. 2011, 13(August (4)):274-282.
7. Denys D., Mantione M., Figee M., van den Munckhof P., Koerselman F., Westenberg H., Bosch A., Schuurman R. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch. Gen. Psychiatry 2010, 67(October (10)):1061-1068.
8. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., Charney D.S. The Yale-Brown obsessive compulsive scale II. Validity. Arch. Gen. Psychiatry 1989, 46:1012-1016.
9. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown obsessive compulsive scale I. Development, use, and reliability. Arch. Gen. Psychiatry 1989, 46:1006-1011.
10. Groenewegen H.J., Wright C.I., Beijer A.V., Voorn P. Convergence and segregation of ventral striatal inputs and outputs. Ann. N. Y. Acad. Sci. 1999, 29(June (877)):49-63.
11. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
12. Kluge M., Schüssler P., Künzel H.E., Dresler M., Yassouridis A., Steiger A. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J. Psychiatr. Res. 2007, 41(December (11)):928-933.
13. Lord C., Hall G., Soares C.N., Steiner M. Physiological stress response in postpartum women with obsessive-compulsive disorder: a pilot study. Psychoneuroendocrinology 2011, 36(January (1)):133-138.
14. Mallet L., Polosan M., Jaafari N., Baup N., Welter M.L., Fontaine D., du Montcel S.T., Yelnik J., Chéreau I., Arbus C., Raoul S., Aouizerate B., Damier P., Chabardès S., Czernecki V., Ardouin C., Krebs M.O., Bardinet E., Chaynes P., Burbaud P., Cornu P., Derost P., Bougerol T., Bataille B., Mattei V., Dormont D., Devaux B., Vérin M., Houeto J.L., Pollak P., Benabid A.L., Agid Y., Krack P., Millet B., Pelissolo A. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N. Engl. J. Med. 2008, 359(November (20)):2121-2134. STOC Study Group.
15. Novakova L., Haluzik M., Jech R., Urgosik D., Ruzicka F., Ruzicka E. Hormonal regulators of food intake and weight gain in Parkinson's disease after subthalamic nucleus stimulation. Neuro Endocrinol Lett. 2011, 32(4):437-441.
16. Rohleder N., Kirschbaum C. The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int. J. Psychophysiol. 2006, 59(March (3)):236-243.